Success with antiretroviral treatment for children in Kigali, Rwanda: Experience with health center/nurse-based care

Médecins Sans Frontières, Kigali, Rwanda.
BMC Pediatrics (Impact Factor: 1.92). 10/2008; 8:39. DOI: 10.1186/1471-2431-8-39
Source: PubMed

ABSTRACT Although a number of studies have shown good results in treating children with antiretroviral drugs (ARVs) in hospital settings, there is limited published information on results in pediatric programs that are nurse-centered and based in health centers, in particular on the psychosocial aspects of care.
Program treatment and outcome data were reported from two government-run health centers that were supported by Médecins Sans Frontières (MSF) in Kigali, Rwanda between October 2003 and June 2007. Interviews were held with health center staff and MSF program records were reviewed to describe the organization of the program. Important aspects included adequate training and supervision of nurses to manage ARV treatment. The program also emphasized family-centered care addressing the psychosocial needs of both caregivers and children to encourage early diagnosis, good adherence and follow-up.
A total of 315 children (< 15 years) were started on ARVs, at a median age of 7.2 years (range: 0.7-14.9). Sixty percent were in WHO clinical stage I/II, with a median CD4% of 14%. Eighty-nine percent (n = 281) started a stavudine-containing regimen, mainly using the adult fixed-dose combination. The median follow-up time after ARV initiation was 2 years (interquartile range 1.2-2.6). Eighty-four percent (n = 265) of children were still on treatment in the program. Thirty (9.5%) were transferred out, eight (2.6%) died and 12 (3.8%) were lost to follow-up. An important feature of the study was that viral loads were done at a median time period of 18 months after starting ARVs and were available for 87% of the children. Of the 174 samples, VL was < 400 copies/ml in 82.8% (n = 144). Two children were started on second-line ARVs. Treatment was changed due to toxicity for 26 children (8.3%), mainly related to nevirapine.
This report suggests that providing ARVs to children in a health center/nurse-based program is both feasible and very effective. Adequate numbers and training of nursing staff and an emphasis on the psychosocial needs of caregivers and children have been key elements for the successful scaling-up of ARVs at this level of the health system.

Download full-text


Available from: Johan van Griensven, Aug 27, 2015
  • Source
    • "According to WHO, task shifting is a " process whereby specifi c tasks are moved, wherever appropriate, to health workers with shorter training… task shifting can make more effi cient use of existing human resources and ease bottlenecks in service delivery " (Chan 2008: 7). For example, in Botswana and Rwanda, task shifting to nurses was developed as a promising strategy to scale up and sustain adult and paediatric antiretroviral treatments, particularly where provider shortages threatened ART rollout (Griensven et al 2008; Monyatsi et al 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The massive scarcity of physicians in India, mainly in rural areas, prompted the Union Ministry of Health and Family Welfare to propose a three-and-a-half year Bachelor of Rural Health and Care degree designed exclusively to serve rural populations. The fierce opposition by powerful medical lobbies forced the proposal to fade away. This paper emphasises the importance of "task shifting" and "non-physician prescribing" in the global context and argues that non-physician healthcare providers would not only increase availability and accessibility to rural healthcare, but also provide an empowered second line of authority, adding to the checks and balances to the exploitative prestige-based hierarchy that pervades this knowledge-intensive service. T he world is facing severe shortage of healthcare profes-sionals on the face of the ever-increasing burden of non-communicable chronic morbidities. The World Health Organisation (WHO) estimates that 57 countries are experien-cing alarmingly low levels of trained health personnel. 1 While a few Asian countries have the required doctor-patient ratio per 1,000 (Japan 2.1, Korea 2, Singapore 1.8 and China 1.4), India has only 0.69 doctors/1,000. 2 WHO estimates that India cannot achieve the recommended target of "one doctor per 1,000 people" till 2028 (Sinha 2012a). India has two healthcare professionals per 1,000 people against the WHO's recommendation of 2.8/1,000. The fi gure drops to 1.4/1,000 on removing census errors from self-reporting of false qualifi cations. Lancet suggests that the Indian health force, if adjusted for qualifi cation gaps, may be only a quarter of WHO targets (Rao et al 2011). While India is short of six lakh doctors, 10 lakh nurses, and two lakh dental surgeons, 40,000 Indian doctors are serving 50% of the British population, and around 50,000 Indian doc-tors are working in the United States (US). About 20% and 10% doctors in Australia and Canada, respectively have received their MBBS degree from India. Reports suggest that 1,157 Indian doctors migrated abroad between April 2010 and March 2011 (Duttagupta 2012; Sinha 2012b). Mass migrations appear to be a problem shared by developing nations as a whole; for instance, WHO reports that 34% of Zimbabwean nurses and 29% of Ghana's physicians are working abroad (Hooper 2008). More importantly, rural India, with 70% of the population, has only 0.39 doctors/1,000 people against 1.33 for urban. Of the available 6,77,000 doctors, 70% work in urban health-settings (Rao et al 2011). This uneven rural-urban distribution is worsened by a "prestige-based hierarchy" in which physi-cians dominate and undermine the potential contributions from non-physician healthcare professionals.
    Economic and political weekly 03/2013; XLVIII(13):112-117.
  • Source
    • "To tackle this health workforce shortage, WHO proposed in 2007 to shift the task of providing ART from physicians to nonphysician clinicians, mainly nurses and clinical officers (World Health Organisation & HIV ⁄ AIDS Programme 2007). Published data from pilot-programmes in Lesotho, Rwanda, Malawi, Swaziland, Zambia, Kenya, Uganda and South Africa, using a nurse-based approach are encouraging (Bedelu et al. 2007; van Griensven et al. 2008; Chang et al. 2009; Cohen et al. 2009; Massaquoi et al. 2009; Shumbusho et al. 2009; Humphreys et al. 2010; Selke et al. 2010). However, most of them examined nurse-based follow-up but not nurse-based initiation of ART. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective In 2007, Lesotho launched new national antiretroviral treatment (ART) guidelines, prioritising tenofovir and zidovudine over stavudine as a backbone together with lamivudine. We compared the rate of adoption of these new guidelines and substitution of first-line drugs by health centers (HC) and hospitals in two catchment areas in rural Lesotho. Methods Retrospective cohort analysis. Patients aged 16years were stratified into a HC- and a hospital-group. Main outcome variables: Type of backbone at ART-initiation (i), substitutions within first line (ii) and type of backbone among patients retained by December 2010 (iii). A multiple logistic regression model including HC vs. hospital, patient characteristics (sex, age, WHO-stage, baseline CD4-count, concurrent pregnancy, concurrent tuberculosis treatment) and year of ART-start, was used. Results Of 3936 adult patients initiated on ART between 2007 and 2010, 1971 started at hospitals and 1965 at HCs. Hospitals were more likely to follow the new guidelines as measured by prescription of backbones without stavudine (Odds-ratio 1.55; 95%CI: 1.32-1.81) and had a higher rate of drug substitutions while on first-line ART (2.39; 1.83-3.13). By December 2010, patients followed at health centres were more likely to still receive stavudine (2.28; 1.83-2.84). Conclusions Health centers took longer to adopt the new guidelines and substituted drugs less frequently. Decentralised ART-programmes need close support, supervision and mentoring to absorb new guidelines and to adhere to them
    Tropical Medicine & International Health 10/2012; 17(10). DOI:10.1111/j.1365-3156.2012.03051.x · 2.30 Impact Factor
  • Source
    • "Zidovudine, lamivudine, efavirenz (n = 9 (2.9%)) Severe hepatotoxicity, including asymptomatic hepatitis, symptomatic hepatitis, and clinical hepatitis 5 (1.7% of 300 nevirapine patients) cases before month 3, including 4 clinical hepatitis cases and 1 grade 3 asymptomatic case 3 (1.0% of 300 nevirapine patients) symptomatic hepatitis cases after a mean 9 months Nevirapine [13] Grade ≥3 skin manifestations, including SJS 16 (5.3% of 300 nevirapine patients) cases, including 2 (0.7%) SJS cases Nevirapine 8736 patient records Tanzania Various combinations Liver toxicity Nevirapine Efavirenz [14] "
    [Show abstract] [Hide abstract]
    ABSTRACT: The present paper describes possible connections between antiretroviral therapies (ARTs) used to treat human immunodeficiency virus (HIV) infection and adverse drug reactions (ADRs) encountered predominantly in the liver, including hypersensitivity syndrome reactions, as well as throughout the gastrointestinal system, including the pancreas. Highly active antiretroviral therapy (HAART) has a positive influence on the quality of life and longevity in HIV patients, substantially reducing morbidity and mortality in this population. However, HAART produces a spectrum of ADRs. Alcohol consumption can interact with HAART as well as other pharmaceutical agents used for the prevention of opportunistic infections such as pneumonia and tuberculosis. Other coinfections that occur in HIV, such as hepatitis viruses B or C, cytomegalovirus, or herpes simplex virus, further complicate the etiology of HAART-induced ADRs. The aspect of liver pathology including liver structure and function has received little attention and deserves further evaluation. The materials used provide a data-supported approach. They are based on systematic review and analysis of recently published world literature (MedLine search) and the experience of the authors in the specified topic. We conclude that therapeutic and drug monitoring of ART, using laboratory identification of phenotypic susceptibilities, drug interactions with other medications, drug interactions with herbal medicines, and alcohol intake might enable a safer use of this medication.
    03/2012; 2012(2090-3448):760706. DOI:10.1155/2012/760706
Show more